Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Obesity 1 Adenocarcinoma of Lung 1

Interventions

Carboplatin 71 Paclitaxel 49 Radiotherapy 44 Pemetrexed 42 Cisplatin 41 Bevacizumab 39 Gemcitabine 27 Docetaxel 27 Erlotinib Hydrochloride 23 Gefitinib 18 pembrolizumab 14 Taxes 13 Vinorelbine 10 Cetuximab 10 Radiation 8 Nivolumab 8 Magnetic Resonance Spectroscopy 8 capmatinib 7 Radiosurgery 7 Platinum 7 Etoposide 7 Surgical Procedures, Operative 6 Radiotherapy, Conformal 6 Mastectomy, Segmental 6 ceritinib 5 aflutinib 5 Specimen Handling 5 Neoadjuvant Therapy 5 Cyclophosphamide 5 Biopsy 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Adenocarcinoma of Lung × Orlistat × Clear all

NCT06818955 2025-02-12

OOTER

Tongji Hospital

Phase 2 Not yet recruiting

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡